Membrane Localization of Atypical Protein Kinase C during Neuroblast Polarization

神经母细胞极化过程中非典型蛋白激酶 C 的膜定位

基本信息

  • 批准号:
    10001981
  • 负责人:
  • 金额:
    $ 6.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-01 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Cell polarity is the organization of the plasma membrane into discrete domains. In animal cells, polarity is particularly important because of their highly ordered, multicellular organization. In order to meet the demands that organized multicellularity places on polarity, animals have evolved specialized machinery, known as the Par complex, that controls polarization in a broad range of cell types. During development, stem cells must polarize before they divide in order to generate cellular diversity. It is the job of the Par complex to direct polarization in stem cells during mitosis. The Par complex consists of the adapter protein Par-6 and atypical Protein Kinase C (aPKC). It is the catalytic activity of aPKC which is responsible for the polarization of downstream components. In order to perform its catalytic duties at the start of mitosis, aPKC must get recruited to the cell membrane, where it polarizes membrane found fate determinants. This proposal is directed at elucidating how aPKC's interactions with lipids contribute to its proper localization and regulation of its catalytic activity. Within aPKC we have identified a lipid binding domain called the C1 domain. We hypothesize that regulation of the aPKC C1 domain governs the membrane recruitment of aPKC. We propose to test this hypothesis by characterizing the regulation of aPKC's C1 domain both at the molecular and cellular levels. Specific Aims: (1) Determine the intramolecular mechanism by which the C1 domain is autoinhibited. (2) Determine how the C1 domain is activated. Research design: To characterize the autoinhibition mechanism of aPKC's C1 domain, we will use mutagenesis strategies to dissect the intramolecular interactions that repress the C1 domain. C1 domain activity will be measured through aPKC's affinity for liposomes in vitro. Kinase activity assays will allow us to uncover how lipid binding affects the catalytic activity of aPKC. We will use Drosophila neuroblasts (neural stem cells) to track the localization of fluorescently-tagged aPKC in vivo. We will image aPKC at high temporal (every 20 seconds) and spatial resolution using live-cell confocal microscopy. From this data, we will compose 3- dimensional reconstructions to visualize the in vivo localization dynamics of aPKC. In addition to evaluating C1 repression, we will explore the modes of C1 activation. We will analyze how aPKC binding partners contribute to the activation of aPKC's C1 domain using liposome binding assays. Additionally, we will explore whether the C1 domain preferentially binds specific lipids by testing aPKC's affinity for liposomes with different lipid compositions. Finally, we will track the localization of phosphoinositide lipids in polarizing neuroblasts in order to address if aPKC localizes to sites of phosphoinositide enrichment in vivo. Learning how the regulation of the C1 domain controls aPKC's localization will provide the required context for addressing larger questions concerning how cells initiate polarization.
项目摘要 细胞极性是质膜组织成离散域的组织。在动物细胞中,极性为 特别重要,因为它们具有高度有序的多细胞组织。为了满足要求 在极性上有组织的多细胞位置,动物已经进化了专业的机械,称为PAR 复杂的,可以控制各种细胞类型的极化。在开发过程中,干细胞必须极化 在它们分裂之前以产生细胞多样性。将PAR复合物引导到极化是 有丝分裂过程中的干细胞。 PAR复合物由衔接蛋白PAR-6和非典型蛋白激酶C组成 (APKC)。 APKC的催化活性负责下游成分的极化。 为了在有丝分裂开始时履行其催化职责,APKC必须招募到细胞膜, 它使膜偏振的地方发现了命运决定因素。该提议旨在阐明APKC的方式 与脂质的相互作用有助于其适当的定位和调节其催化活性。之内 APKC我们已经确定了一个称为C1域的脂质结合域。我们假设对 APKC C1域控制APKC的膜募集。我们建议通过 表征分子和细胞水平上APKC C1结构域的调节。具体目的:(1) 确定自身抑制C1结构域的分子内机制。 (2)确定C1的方式 域已激活。研究设计:为了表征APKC C1域的自动抑制机制,我们 将使用诱变策略来剖析抑制C1结构域的分子内相互作用。 C1域 活性将通过APKC在体外对脂质体的亲和力进行测量。激酶活动分析将使我们能够 发现脂质结合如何影响APKC的催化活性。我们将使用果蝇神经细胞(神经茎 细胞)跟踪体内荧光标记的APKC的定位。我们将在高时空图像APKC(每个 20秒)和使用活细胞共聚焦显微镜的空间分辨率。从这些数据中,我们将构成3- 尺寸重建以可视化APKC的体内定位动力学。除了评估C1 抑制,我们将探索C1激活的模式。我们将分析APKC绑定合作伙伴如何贡献 使用脂质体结合测定法激活APKC的C1结构域。此外,我们将探索是否 C1结构域优先通过测试APKC对具有不同脂质的脂质体的亲和力来结合特定的脂质 组成。最后,我们将跟踪磷酸肌醇脂质在偏振神经细胞中的定位,以便为了 地址如果APKC定位于体内磷酸肌醇富集的位点。了解C1的调节如何 域控制APKC的本地化将为解决有关的更大问题提供所需的上下文 细胞如何启动极化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bryce LaFoya其他文献

Bryce LaFoya的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bryce LaFoya', 18)}}的其他基金

Proliferative asymmetry in the neural stem cell lineage established by asymmetric cell division
由不对称细胞分裂建立的神经干细胞谱系的增殖不对称性
  • 批准号:
    10664431
  • 财政年份:
    2023
  • 资助金额:
    $ 6.53万
  • 项目类别:

相似海外基金

Mechanisms of Mammalian Genetic Hearing Loss
哺乳动物遗传性听力损失的机制
  • 批准号:
    10660134
  • 财政年份:
    2023
  • 资助金额:
    $ 6.53万
  • 项目类别:
Regulation of Human Tumorigensis by Cancer Specific NXF1 Adaptor Proteins
癌症特异性 NXF1 接头蛋白对人类肿瘤发生的调节
  • 批准号:
    10411472
  • 财政年份:
    2022
  • 资助金额:
    $ 6.53万
  • 项目类别:
Regulation of epidermal growth and differentiation through mRNA export
通过 mRNA 输出调节表皮生长和分化
  • 批准号:
    10675700
  • 财政年份:
    2022
  • 资助金额:
    $ 6.53万
  • 项目类别:
Spherical Nucleic Acid nano-architectures as first-in-class cGAS agonists for the immunotherapeutic treatment of Glioblastoma.
球形核酸纳米结构作为一流的 cGAS 激动剂,用于胶质母细胞瘤的免疫治疗。
  • 批准号:
    10539146
  • 财政年份:
    2022
  • 资助金额:
    $ 6.53万
  • 项目类别:
Regulation of Human Tumorigensis by Cancer Specific NXF1 Adaptor Proteins
癌症特异性 NXF1 接头蛋白对人类肿瘤发生的调节
  • 批准号:
    10596156
  • 财政年份:
    2022
  • 资助金额:
    $ 6.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了